New treatment option for Chronic Pain
Official title Impact of QoLibri Medical Device on the Consequences of Chronic Pain: a Randomized Controlled Trial
ClinicalTrials.gov ID: NCT06841276
What this study is testing
- What it's testing
- A superiority study evaluating the impact of the QoLibri Software as Medical Device on functional and psychological consequences of chronic pain in primary care patients. A prospective, cluster-randomized, wait list, controlled multicentre study with the main objective of evaluating the effectiveness of the QoLibri Digital Therapy on Quality of Life improvement in patients living with chronic pain.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient experiencing at least moderate pain (on the Categorical Pain Scale) for more than 3 months
- Patient with a BPI interference score ≥ 3 in at least 3 out of 7 dimensions
- Patient with a smartphone and an internet connection at the place of use
- Patient affiliated with a social security system or benefiting from such a system
You likely can't join if
- Patient opposing participation in the study
- Patient with severe anxiety and/or depressive disorders (especially a suicidal risk)
- Patient presenting one or more barriers to the initiation of cognitive-behavioral therapy (significant social difficulties, low adherence to current...
- Adult patient under legal protection measures (guardianship, legal safeguard, psychiatric care, or deprived of liberty by judicial or administrative...
The study team makes the final eligibility decision.
Where it's taking place
- Nailloux, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Nailloux, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.